Impaired LTB4-induced neutrophil chemotactic directionality in myelodysplastic neoplasms patients

Xinyan Xie1,2,3, Yumei Liu1,2,3, Liyan Yang1,2,3

  • 1Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Abstract

Insights

Myelodysplastic Neoplasm patients experience frequent infections due to impaired neutrophil function, specifically reduced chemotaxis and reactive oxygen species production. Directionality of neutrophil migration is a key factor linked to infection risk.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Myelodysplastic Neoplasm (MDS) patients have a high risk of infection, a major cause of mortality.
  • Neutrophil dysfunction is implicated, but specific functional defects are not well understood.

Purpose of the Study:

  • To investigate neutrophil functional defects in de novo MDS patients.
  • To evaluate neutrophil chemotaxis, reactive oxygen species (ROS) production, and neutrophil alkaline phosphatase (NAP) activity.

Main Methods:

  • Studied 90 participants (controls and MDS patients).
  • Assessed neutrophil chemotaxis to leukotriene B4 (LTB4) using TAXIScan-FL.
  • Measured ROS production via chemiluminescence and NAP activity via enzymatic staining.

Main Results:

  • MDS patients had higher empirical antimicrobial therapy (EAT) rates.
  • Neutrophil migration towards LTB4 was impaired in velocity and directionality.
  • Compromised ROS and NAP activity were observed in MDS patients.
  • Chemotactic directionality correlated with EAT rates.

Conclusions:

  • Impaired neutrophil chemotaxis (speed and directionality) and reduced ROS/NAP activity contribute to infection risk in MDS.
  • Chemotactic directionality is a significant factor associated with antimicrobial therapy needs.
  • Targeting specific neutrophil defects may improve infection management in MDS patients.